![Amit Kohli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Amit Kohli is a Chief Executive Officer & Director at Antev Ltd. He is on the Board of Directors at Antev Ltd. Mr. Kohli was previously employed as a Chief Operating Officer by Pharnext SA. He received his undergraduate degree from the University of Pune and an MBA from Management Development Institute.
Aktive Positionen von Amit Kohli
| Unternehmen | Position | Beginn |
|---|---|---|
| POXEL | Direktor/Vorstandsmitglied | 31.07.2025 |
Antev Ltd.
 Antev Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for cancer patients | Vorstandsvorsitzender | 01.11.2020 |
Ehemalige bekannte Positionen von Amit Kohli
| Unternehmen | Position | Ende |
|---|---|---|
| PHARNEXT SCA | Geschäftsführer | - |
Ausbildung von Amit Kohli
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
University of Pune
 University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
 Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Management Development Institute
 Management Development Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antev Ltd.
Antev Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for cancer patients | Health Technology |
Wählen Sie MarketScreener 
